In one paragraphArticle in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Gaston PascualDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0002-7154-5775 Agustina SabaterDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0003-1412-3506 Juan BizzottoDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0002-7844-2162 Rocio SeniukDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.
Pablo SanchisDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0002-0243-8036 Sabrina Ledesma-BazanDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0003-2725-9760 Estefania LabancaDepartment of Genitourinary Medical Oncology and The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Carlos ScorticatiDepartamento de Urología, Ciudad Autónoma de Buenos Aires (CABA), Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires C1120AAF, Argentina.
Osvaldo MazzaDepartamento de Urología, Ciudad Autónoma de Buenos Aires (CABA), Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires C1120AAF, Argentina.
Elba VazquezDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0002-0460-0236 Ayelen ToroDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0002-5169-2006 Federico PradaInstituto de Tecnología (INTEC), Universidad Argentina de la Empresa (UADE), Buenos Aires C1073AAO, Argentina.
Geraldine GueronDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0002-9283-7451 Javier CotignolaDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina.ORCID 0000-0003-4473-9854 Funding
Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2019-03215Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2021-GRF-TI-00126Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT-2021-III-A-00080Fundacion Florencio Fiorini Ayelen Toro
6 · The paper itselfAbstract
BACKGROUND/
objectivesProstate cancer (PCa) is the leading malignancy and the third most common cause of cancer-related death in Argentinian men. Predicting outcomes in localized PCa remains difficult due to tumor heterogeneity. In this study, we assessed the impact of
methodsWe genotyped blood samples from 123 PCa patients for
results
conclusionsThis study has identified
Indexed as
androgen receptorAPEX1biochemical relapsegenetic biomarkerspolymorphismsprostate cancer
Identifiers
PMID39594771
PMCPMC11592882
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390